Thomas W. Leonard
31Patents
18h-index
37Co-inventors
81Inventor score
Filing activity: Mar 4, 1986 → Nov 8, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4794001A | Formulations providing three distinct releases | Human Necessities | 173 | Expired |
| US4728512A | Formulations providing three distinct releases | Human Necessities | 135 | Expired |
| US4904476A | Formulations providing three distinct releases | Human Necessities | 125 | Expired |
| US8119159B2 | Solid oral dosage form containing an enhancer | Human Necessities | 109 | Active |
| US7704977B2 | Solid oral dosage form containing an enhancer | Human Necessities | 104 | Active |
| US5536729A | Rapamycin formulations for oral administration | Human Necessities | 91 | Expired |
| US8883203B2 | Solid oral dosage form containing an enhancer | Human Necessities | 91 | Active |
| US5559121A | Rapamycin formulations for oral administration | Human Necessities | 84 | Expired |
| US8883201B2 | Solid oral dosage form containing an enhancer | Human Necessities | 83 | Active |
| US6855703B1 | Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds | Human Necessities | 64 | Expired |
| US7427609B2 | Treatment of conditions relating to hormone deficiencies by administration of progestins | Human Necessities | 61 | Expired |
| US5530006A | Rapamycin formulation for IV injection | Human Necessities | 53 | Expired |
| US8076319B2 | Treatment of conditions relating to hormone deficiencies by administration of progestins | Human Necessities | 52 | Active |
| US5516770A | Rapamycin formulation for IV injection | Human Necessities | 41 | Expired |
| US7800498B2 | Occupancy sensor powerbase | Physics | 32 | Active |
| US5616588A | Rapamycin formulation for IV injection | Human Necessities | 30 | Expired |
| US4820525A | Transdermal drug delivery system | Human Necessities | 25 | Expired |
| US7560696B2 | Adjustable sensor | Emerging Cross-Sectional Technologies | 20 | Active |
| US4789660A | Insulin administration using methyl and propyl paraben | Human Necessities | 16 | Expired |
| US5538737A | Oral compositions of H.sub.2 -antagonists | Human Necessities | 16 | Expired |
| US8008802B2 | Bi-level switching with power packs | Emerging Cross-Sectional Technologies | 9 | Active |
| US6992075B2 | C(14) estrogenic compounds | Human Necessities | 6 | Expired |
| US4873266A | Menthone enhancement of transdermal drug delivery | Human Necessities | 4 | Expired |
| US4888360A | Carvone enhancement of transdermal drug delivery | Human Necessities | 2 | Expired |
| US8999383B2 | Compositions of GnRH related compounds and processes of preparation | Chemistry; Metallurgy | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.